Professor Mikhail Blagosklonny is one of the greatest things ever to happen to the world of science. With certainly a calling for research in the field of oncology and aging, professor Mikhail has committed much of his research time mulling the best approaches to the management, prevention, and treatment of cancer. the scholar with a keen focus on the age old question of aging has also sought to make us understand the secrets of aging while proposing ways of its possible conquest.
Mikhail Blagosklonny enrolled in the Pavlov State Medical University in St. Petersburg after high school. While in this university, he earned an M.D. in internal medicine and proceeded to complete a Ph.D. in cardiology and experimental medicine. Following his graduation with a Ph.D., Mikhail got hired by the New York Medical college Valhalla to the position of an associate professor. He then moved to the Ordway Research Institute where he became the senior scientist and stayed in the position until 2009. From Ordway Research Institute, Mikhail joined the Roswell Park Cancer Institute becoming a professor of oncology.
Follow Mikhail on Loop
Professor Mikhail currently works at the Rosewell Park Cancer Institute in New York USA. His research interests fall within the fields of cellular and molecular biology, clinical research on tumor suppressors and oncogenes, apoptosis and signal transduction, the cell cycle and cancer drugs, aging and aging diseases.
Professor Mikhail has written more than 3000 articles, book chapters, and reviews.his is the editor in chief and founder of the cell cycle. Co-editor and the co-founder of the aging, oncoscience, and oncotarget. He has also served as the associate editor for cancer research, an international journal of cancer, cell death, and differentiation, cancer biology and therapy, the American journal of pathology and autophay.
Professor Mikhail TOR signaling hypothesis. TOR is a nutrient sensing protein kinase that regulates growth and metabolism in eukaryotes. This kinase is the target for inhibition by the drug rapamycin pioneered by Mikhail for anti-aging.
Visit ResearchGate to know more about Mikhail’s latest work.